서브메뉴
검색
Frequency of Pharmacotherapy and Psychosocial Therapy Among Anxiety, Opioid Use, and Co-Occurring Disorders in an Outpatient Behavioral Health Program
Frequency of Pharmacotherapy and Psychosocial Therapy Among Anxiety, Opioid Use, and Co-Occurring Disorders in an Outpatient Behavioral Health Program
상세정보
- 자료유형
- 학위논문 서양
- 최종처리일시
- 20260202105249
- ISBN
- 9798291590850
- DDC
- 610.73
- 서명/저자
- Frequency of Pharmacotherapy and Psychosocial Therapy Among Anxiety, Opioid Use, and Co-Occurring Disorders in an Outpatient Behavioral Health Program
- 발행사항
- [Sl] : Case Western Reserve University, 2025
- 발행사항
- Ann Arbor : ProQuest Dissertations & Theses, 2025
- 형태사항
- 91 p
- 주기사항
- Source: Dissertations Abstracts International, Volume: 87-03, Section: B.
- 주기사항
- Advisor: Morris, Diana.
- 학위논문주기
- Thesis (Ph.D.)--Case Western Reserve University, 2025.
- 초록/해제
- 요약Background: A growing body of literature supports the increasing prevalence of co-occurring anxiety and opioid use disorders. Diagnosing an anxiety disorder alongside an opioid use disorder is complex. Evidence indicates that individuals with co-occurring disorders receive fragmented or isolated care and face higher morbidity and mortality rates than those with a single condition. Treatment recommendations for these disorders follow different trajectories, often being multifaceted and conflicting. Psychosocial and pharmacotherapies play significant roles in treatment modalities; however, current empirical evidence lacks recommendations for integrating methods to manage co-occurring disorders.Problem: Research on pharmacotherapy and psychosocial therapies for individuals with co-occurring anxiety and opioid use disorders is limited. Although treatment modalities for each disorder individually are well established in the literature, those with both conditions face poorer treatment outcomes, higher relapse rates, and increased morbidity and mortality.Purpose: The purpose of this exploratory study was to examine the frequency of pharmacotherapy and psychosocial therapy among individuals diagnosed with anxiety disorders, opioid use disorders, and co-occurring disorders within an outpatient mental health and substance use treatment program.Method: This retrospective, descriptive, comparative, cross-sectional chart review analyzed data from a community outpatient mental health and substance use treatment center. The study examined differences in pharmacotherapy and psychosocial therapy among 250 patients diagnosed with anxiety disorders, opioid use disorders, and co-occurring disorders. The frequency of each disorder was assessed across groups. Data analysis included descriptive statistics (frequencies and percentages) and a chi-square test of independence with cross-tabulations to compare pharmacotherapy and psychosocial therapy use across diagnostic groups.Results: This study confirms that generalized anxiety disorder is the most common among those with opioid use disorder. Access to pharmacotherapy was consistent across groups. It suggests a link between psychosocial therapy and opioid use with co-occurring disorders (p.001). Results showed varying outcomes for combined treatments. The implications involve integrating mental health and substance use treatment. Additionally, variations in anxiety disorder subtypes among opioid users suggest a need for further investigation into how specific opioids affect anxiety symptoms and treatment outcomes.
- 일반주제명
- Nursing
- 일반주제명
- Health sciences
- 일반주제명
- Behavioral sciences
- 일반주제명
- Mental health
- 일반주제명
- Social psychology
- 키워드
- Anxiety
- 키워드
- Pharmacotherapy
- 기타저자
- Case Western Reserve University Nursing
- 기본자료저록
- Dissertations Abstracts International. 87-03B.
- 전자적 위치 및 접속
- 로그인 후 원문을 볼 수 있습니다.
MARC
008260126s2025 us c eng d■001000017360004
■00520260202105249
■006m o d
■007cr#unu||||||||
■020 ▼a9798291590850
■035 ▼a(MiAaPQ)AAI32275752
■040 ▼aMiAaPQ▼cMiAaPQ
■0820 ▼a610.73
■1001 ▼aMccullough, Jessica Nicole.
■24510▼aFrequency of Pharmacotherapy and Psychosocial Therapy Among Anxiety, Opioid Use, and Co-Occurring Disorders in an Outpatient Behavioral Health Program
■260 ▼a[Sl]▼bCase Western Reserve University▼c2025
■260 1▼aAnn Arbor▼bProQuest Dissertations & Theses▼c2025
■300 ▼a91 p
■500 ▼aSource: Dissertations Abstracts International, Volume: 87-03, Section: B.
■500 ▼aAdvisor: Morris, Diana.
■5021 ▼aThesis (Ph.D.)--Case Western Reserve University, 2025.
■520 ▼aBackground: A growing body of literature supports the increasing prevalence of co-occurring anxiety and opioid use disorders. Diagnosing an anxiety disorder alongside an opioid use disorder is complex. Evidence indicates that individuals with co-occurring disorders receive fragmented or isolated care and face higher morbidity and mortality rates than those with a single condition. Treatment recommendations for these disorders follow different trajectories, often being multifaceted and conflicting. Psychosocial and pharmacotherapies play significant roles in treatment modalities; however, current empirical evidence lacks recommendations for integrating methods to manage co-occurring disorders.Problem: Research on pharmacotherapy and psychosocial therapies for individuals with co-occurring anxiety and opioid use disorders is limited. Although treatment modalities for each disorder individually are well established in the literature, those with both conditions face poorer treatment outcomes, higher relapse rates, and increased morbidity and mortality.Purpose: The purpose of this exploratory study was to examine the frequency of pharmacotherapy and psychosocial therapy among individuals diagnosed with anxiety disorders, opioid use disorders, and co-occurring disorders within an outpatient mental health and substance use treatment program.Method: This retrospective, descriptive, comparative, cross-sectional chart review analyzed data from a community outpatient mental health and substance use treatment center. The study examined differences in pharmacotherapy and psychosocial therapy among 250 patients diagnosed with anxiety disorders, opioid use disorders, and co-occurring disorders. The frequency of each disorder was assessed across groups. Data analysis included descriptive statistics (frequencies and percentages) and a chi-square test of independence with cross-tabulations to compare pharmacotherapy and psychosocial therapy use across diagnostic groups.Results: This study confirms that generalized anxiety disorder is the most common among those with opioid use disorder. Access to pharmacotherapy was consistent across groups. It suggests a link between psychosocial therapy and opioid use with co-occurring disorders (p.001). Results showed varying outcomes for combined treatments. The implications involve integrating mental health and substance use treatment. Additionally, variations in anxiety disorder subtypes among opioid users suggest a need for further investigation into how specific opioids affect anxiety symptoms and treatment outcomes.
■590 ▼aSchool code: 0042.
■650 4▼aNursing
■650 4▼aHealth sciences
■650 4▼aBehavioral sciences
■650 4▼aMental health
■650 4▼aSocial psychology
■653 ▼aAnxiety
■653 ▼aSubstance use disorders
■653 ▼aCo-occurring mental health
■653 ▼aPharmacotherapy
■653 ▼aPsychosocial therapies
■653 ▼aOutpatient mental health treatment
■690 ▼a0566
■690 ▼a0602
■690 ▼a0569
■690 ▼a0347
■690 ▼a0451
■71020▼aCase Western Reserve University▼bNursing.
■7730 ▼tDissertations Abstracts International▼g87-03B.
■790 ▼a0042
■791 ▼aPh.D.
■792 ▼a2025
■793 ▼aEnglish
■85640▼uhttp://www.riss.kr/pdu/ddodLink.do?id=T17360004▼nKERIS▼z이 자료의 원문은 한국교육학술정보원에서 제공합니다.
